Abstract. Fasting plasma concentrations of sulphur Key words: continuous ambulatory peritoneal dialysis; cysteine; haemodialysis; homocysteine; sulphur amino amino acids (sAA) were measured in nine non-dialysed ( ND) chronic uraemic patients on conservative treat-acid; taurine; uraemia ment, 10 patients on continuous ambulatory peritoneal dialysis (CAPD), nine patients on haemodialysis ( HD) treatment, and 10 healthy subjects (HS ). Methionine and taurine concentrations were significantly decreased in the CAPD and HD patients and tended to be low Introduction in the ND patients. Cysteine sulphinic acid (CSA) levels were significantly higher in all patient groups. Many abnormalities are observed in plasma sulphur Total (t), free (f ), and protein-bound (pb ) homocyst-amino acid (sAA) concentrations in patients with eine ( Hcy) and cysteine (Cys) were significantly chronic renal failure (CRF ). Methionine, the essential increased in all patient groups. Serine, a substrate for amino acid, was found to be normal [1][2][3]. cystathionine synthesis from Hcy, showed significantly Accumulations of homocysteine (Hcy) and cysteine lower concentrations in all patient groups. The percent-(Cys) have been reported [4][5][6]. Cysteine sulphinic ages of pbHcy were significantly higher in the CAPD acid (CSA), an intermediate precursor in the biosynand HD patients than in the ND patients (P<0.0001, thesis of taurine, has been reported to be high in P=0.002 respectively) or in the HS (P<0.0001, P= patients on haemodialysis ( HD) and continuous ambu-0.008 respectively), whereas the percentages of pbCys latory peritoneal dialysis (CAPD) treatment [7 ]. in CAPD and HD patients were significantly higher Plasma and muscle taurine deficiency are well described than in ND patients (P=0.0006, P=0.009 respectively) in uraemic patients [1,2,[7][8][9][10][11]. Taurine deficiency has and tended to be high without reaching statistical been considered a potential cause of dilated cardiomysignificance compared to the HS. A single HD treat-opathy [12]. The role of taurine in modulating calcium ment decreased tHcy by 26%, fHcy by 39%, and pbHcy fluxes, cardiac contractility, and congestive heart failby 22%, as well as tCys by 40%, fCys by 54%, and ure has been examined in several studies [13][14][15], but pbCys by 27%. The tHcy concentration, although its exact physiological function still not known [16 ]. decreased by HD treatment, remained higher than in Hcy is metabolized by trans-sulphuration to Cys via HS, whereas tCys was normalized by the dialysis cystathionine or by remethylation to methionine. session. In addition, HD treatment significantly Plasma Hcy exists in different forms, including proteindecreased the plasma concentrations of methionine, bound homocysteine ( pbHcy) ( 65%) and free homo-CSA, taurine, and serine. We conclude that, except for cysteine (fHcy) ( 35%), which consists of reduced methionine and taurine, the plasma sAA in their fraction, oxidized fraction and Hcy-Cys mixed disulphdifferent forms are markedly increased in dialysed and ide [17,18]. Hcy has recently attracted more interest non-dialysed uraemic patients. The percentages of because of its probable association with cardiovascular pbHcy and pbCys were significantly higher in dialysed disease. Hyperhomocysteineaemia has been reported than in ND uraemic patients. HD treatment can nor-in numerous studies in chronic uraemic patients on malize the tCys concentration, and decrease the tHcy dialysis or on conservative treatment or in patients concentration but not normalize it. The observed hyp-who have received a kidney transplant [19][20][21][22][23][24]. erhomocysteineaemia and low taurine levels may conIn this study we have carefully evaluated the plasma tribute to the high incidence of cardiovascular disease concentrations of the different forms of sAA in HD, in uraemic patients.
session. The HD patients were studied at the mid-week or decreasing the different fractions of Hcy and Cys and end of the week dialysis session. other sAA.
Blood samples for measurement of amino acids were drawn in evacuated cooled tubes containing EDTA and centrifuged immediately at 2300 g for 15 min at 4°C. The
Subjects and methods
plasma was separated carefully into two parts. For determination of non-sulphur amino acids and free sulphur amino Subjects acids, 1.0 ml of the plasma was immediately mixed with 0.1 ml of 30% sulphosalicylic acid (SSA), kept at 4°C for Four groups of individuals were studied. Group 1 consisted 1 h, centrifuged at 2300 g and 4°C for 20 min, the supernatant of 10 apparently healthy subjects ( HS), five men and five was collected and filtered through a 0.45 mm membrane filter women, aged 31-52 years, who served as reference indi-and stored at −70°C until analysed. The remaining nonviduals. Group 2 consisted of nine ND uraemic patients on deproteinized plasma was stored at −70°C until analysed conservative treatment, five men and four women, aged for total homocysteine (tHcy) and total cysteine (tCys). 26-79 years. Their mean creatinine clearance was 7.4 ml/min
For the determination of free homocysteine (fHcy) and (range 4-19 ml/min). Group 3 consisted of 10 uraemic free cysteine (fCys), 0.1 ml of the deproteinised plasma was patients on CAPD for 1-38 (mean 14) months, four men reduced with 10 ml of 10% (v/v) tri-n-butylphosphine ( TBP) and six women, aged 38-70 years. Group 4 consisted of nine in dimethylformamide (DMF ) for 30 min at 4°C. Reduction patients who underwent HD for 5-32 (mean 17) months, of the aminothiols in plasma for determination of tHcy and five men and four women, aged 32-86 years (Table 1 ) . They tCys was achieved by treating 0.2 ml of non-deproteinized were dialysed for 4 h three times weekly with bicarbonate as plasma with 20 ml of 10% TBP in DMF for 30 min at 4°C buffer in the dialysis fluid. Dialysers with cellulose acetate in order to decouple aminothiols from plasma protein and (n=3 ), hemophan (n=5) or PAN (n=1) membranes were to reduce them. Thereafter the plasma was deproteinized used.
with 20 ml of 30% SSA, centrifuged, and filtered as for free All patients were receiving various medications, mainly amino acids. Thus all thiol components in the plasma were antihypertensive agents, diuretics, sodium bicarbonate and converted and analysed in the reduced form. External standcalcium carbonate and all were prescribed a daily supplement ards containing 25 mM Hcy and 100 mM Cys were treated of water-soluble vitamins, including pyridoxine 10 mg/day, with reducing agent as for the plasma. but not folic acid or B 12
. None of the patients was treated Derivatization was based on precolumn derivatization of with corticosteroids or cytotoxic drugs. All had normal Hcy and Cys with 6-aminoquinolyl-N-hydroxysuccinimidyl transaminase levels in plasma and no signs of liver disease. carbamate (AQC ) [25] ; in brief, 10 ml of a sample or standard The daily protein intake of the dialysed patients was estim-was diluted with 70 ml 200 mM borate buffer (pH 8.8) conated from the protein equivalent of total nitrogen appearance taining 5 mM disodium EDTA, and was rapidly derivatized (nPNA), which was calculated from the urea appearance by the addition of reconstituted 20 ml of AQC reagent and rate. The mean values were above 1 g/kg body wt/day in then 75 ml of 62.5 mM acetic acid was added within 40-80 both the HD and CAPD patients ( Table 1) .
s. Thereafter the samples were kept at 10°C in an autosampler The protocol of the study was approved by the Ethics of the HPLC. Derivatized thiol components have sufficient Committee of Karolinska Institute at Huddinge University stability at acidic pH and at 10°C. To investigate the recovery Hospital, Stockholm, and informed consent was obtained of the method, known amounts of synthetic Hcy and Cys from each individual.
were added to 0.2 ml aliquots of plasma before adding TBP in the procedure of the assay of Hcy and Cys. The recoveries obtained for Hcy and Cys added to plasma were 96.6% and
Analytical methods
95.4% respectively. The HPLC work station from Waters consisted of Venous blood samples from the patients and HS were Millennium Chromatography Manager (version 2.10) for collected in the morning after overnight fasting. Post-dialysis data acquisition, peak integration, report presentation and blood samples were drawn 4 h later from seven patients on HD, who continued fasting until the end of the dialysis for the system control of 600S pump controller, 616 LC 42±3 3 3 ± 5 3 6 ± 4 3 1 ± 4 Serum creatinine (mmol/l ) 87±12 535±129 829±244 715±209 Blood urea (mmol/l) 5±1 3 0 ± 9 2 1 ± 3 2 0 ± 4 Creatinine clearance (ml/min) 99±12 7.4±5.1 --HS, healthy subjects; ND, non-dialysed patients; HD, haemodialysis; CAPD, continuous ambulatory peritoneal dialysis; nPNA, normalized protein equivalent of total nitrogen appearance.
Gradient Pump, 717 Plus Auto sampler with a Heating/ and fCys were significantly higher in each of the three cooling Module, Column Oven, Helium Degasser and 474 patient groups than in the HS. The concentration of Scanning Fluorescence Detector.
pbHcy was calculated by subtracting fHcy from tHcy Separation was achieved at 37°C on an AccQ Tag [26, 27] and that of protein-bound cysteine (pbCys) 3.9×150 mm, 4 mm, silica-based Nova-Pak C18 reversed-was calculated similarly. Concentrations of pbHcy phase column ( Waters). Hcy and Cys were eluted in an increased significantly in the three patient groups. The acetate-phosphate buffer system containing buffer A concentrations of pbCys also increased significantly in ( 19.04 g/l sodium acetate and 970 ml of triethylamine titrated the dialysed patient groups and tended to be high in to pH 5.75 with phosphoric acid), buffer B (acetonitrile ( ACN)) and buffer C (ultra-pure 18 mega-ohm water the ND patients.
( ELGA)). In the gradient elution programme, slightly modi- Figures 1 and 2 show that the decreases in percentfied from the original method [ 25] , buffer A was mixed with ages of pbHcy and pbCys were not significant in the buffer B to the following percentages of buffer B admixture: ND patients, compared to the HS, but the pbHcy 0% (initial ), 1% (1 min), 3% ( 16 min), 6% (25 min), 15% (25 percentages were significantly higher in the HD and min), 15% (40 min), and 18% (50 min). Subsequent samples CAPD patients than in the HS and ND patients, and were injected onto the column following 4 min washing with the pbCys percentages were significantly higher in the 60% ACN in water and 9 min re-equilibration with 100% of HD and CAPD patients compared to the ND patients, buffer A. Fluorescence was measured at 250 nm (excitation) and 395 nm (emission).
The determination of amino acids in plasma, except Hcy and Cys, was carried out using HPLC and fluorescence detection. The method is based on automated precolumn derivatization of amino acids with orthophthalaldehyde (OPA)/3-mercaptopropionic acid ( 3-MPA), as described elsewhere [7] .
Serum creatinine, serum urea and serum albumin concentrations were determined by routine biochemical laboratory methods (Table 1 ) in the clinical laboratory at the hospital using the Hitachi 737, Automatic Analyser (Naka Works, Hitachi Ltd., Tokyo, Japan).
Statistical analysis
The differences between the HS and the patient groups were determined with ANOVA. When ANOVA was found to be significant at P<0.05, we used Dunnett's test to compare the differences between the HS and patient groups. Differences between the three patient groups were analysed by ANOVA, followed by Dunnett's test with Bonferroni's correction for multiple comparisons between the groups. Differences between the prehaemodialysis and posthaemodialysis samples were determined by using the paired t test. All values are expressed as mean±SD unless otherwise indicated.
Results

Fig. 1. Percentages of plasma protein-bound homocysteine in
The mean levels of the different forms of Hcy and Cys healthy subjects ( HS), non-dialysed ( ND) chronic uraemic patients, haemodialysis (HD), and CAPD patients.
are presented in Table 2 . Total and free plasma Hcy lysis session. The concentrations of tHcy and pbHcy remained elevated after dialysis, as compared to the HS, but fHcys concentrations were normalized. Similarly, total, free and protein-bound Cys concentrations ( Table 3) decreased significantly during dialysis, and dialysis normalized tCys and pbCys concentrations, but the fCys concentration was significantly lower after dialysis, as compared to the HS. HD treatment decreased tHcy by 26%, fHcy by 39%, and pbHcy by 22%, whereas tCys decreased by 40%, fCys by 54%, and pbCys by 27%. Table 2 shows that the mean values of plasma methionine and taurine concentrations were significantly reduced in the HD and the CAPD patients and tended to be low, without reaching significance, in the ND patients. Plasma CSA levels were significantly elevated in the three patient groups. The mean plasma serine concentration fell significantly in all patient groups. A single haemodialysis treatment significantly decreased the plasma concentrations of methionine, CSA, taurine and serine (Table 3 ).
The ratios (Table 4 ) of tHcy to tCys, fHcy to fCys, and pbHcy to pbCys in plasma were significantly higher in all patient groups than in the HS, and the ratios of methionine to tHcy, methionine to tCys, taurine to tHcy, taurine to tCys, and taurine to CSA were significantly decreased in the patient groups, but the ratio of taurine to methionine in the patients remained the same as in the HS. The ratio of glycine to serine was significantly increased in the HD and CAPD and tended to be high in the ND patients, 
Discussion
and tended to be higher than the HS, without reaching statistical significance.
The present study confirms our previous results, in the Total, free, and protein-bound Hcy concentrations dialysed uraemic patients, which showed a decrease in ( Table 3 ) decreased significantly during the haemodia-plasma taurine concentrations in the presence of high concentrations of cysteine sulphinic acid, the immedi- Table 3 . The effect of haemodialysis treatment on the concentrations ate precursor of taurine [7] . The plasma methionine of amino acids (mmol/l ), serum creatinine and blood urea concentrations significantly decreased in both dialysed (mean±SD) patient groups, whereas the levels tended to be low in the ND patients ( it was two to three times higher in the dialysed patients.
Blood urea, mmol/l 2 1 ± 3 5.9±1.7* 72
The pbHcy and pbCys as percentages of tHcy and tCys, respectively (Table 2 ) , were higher in the dialysis *P<0.001; †P<0.01; ‡P<0.05 when compared to Pre-HD; aP<0.001 when compared to healthy subjects in Table 2. patients than in the ND patients. This seems paradox- , a higher reduction several compounds, including the amino acid tryptophan and certain drugs such as phenytoin and digoxin, when using a high-flux membrane (49%) than with a low-flux membrane ( 41%). Thus we have no good is reduced in uraemia, presumably due to displacement by compounds accumulating in renal failure [31, 32] . explanation for the observation that even with the lowflux membrane the reduction was greater than in our Apparently, the binding of Hcy and Cys to protein is not influenced by the same mechanism. A plausible patients, many of whom were using normal-flux membranes. Kang et al.
[40] found a reduction in pbHcy explanation of the high percentage of pbHcy and pbCys may be that fHcy and fCys are easily dialysable of 23%, similar to our data, whereas Smolin et al. [6] noted only 11% decline in pbHcy following low-flux while pbHcy and pbCys are not.
Previous studies have shown that plasma levels of dialysis. HD treatment apparently failed to normalize tHcy Hcy and Cys increase with age [33, 34] . Our ND and HD patients were, on average, older than the controls, and the obvious explanation is that the protein-bound fraction is the largest fraction of Hcy. On the other and it cannot be excluded that this may have contributed to the high Cys and Hcy levels observed. However, hand, tCys, which was proportionally much less elevated than tHcy, normalized after dialysis treatment age had little effect and should therefore be much less important than the remarkable increase (more than because plasma Cys is present mainly as a free fraction.
Haemodialysis treatment reduced plasma fHcy by twofold ) due to renal failure.
Of the non-sulphur amino acids presented, we 39% and plasma fCys by 54% ( Table 3 ). The free form may be present in reduced or oxidized (disulphide) observed a decrease in serine levels in our patients. Serine is a substrate for the synthesis of cystathionine form or as mixed disulphides, and there seems to be a complex relationship between these forms and the by condensing with Hcy and it is converted to glycine in the restoration of methylenetetrahydrofolate from protein-bound forms of these compounds [41 ] . The lower percentage decrease in fHcy than in fCys inditetrahydrofolate. Our results are similar to those in previous reports that plasma serine levels were low in cates that fHcy is less efficiently dialysed, suggesting that a higher proportion is present as disulphide, which CRF [5, 24, 35] . The low plasma serine concentrations found in uraemic patients may point to enhanced has a molecular weight twice as high as the reduced form and therefore has a lower diffusive clearance. catabolism of Hcy through the trans-sulphuration route. However, oral supplementation of serine showed Wilcken et al. [5 ] found a decline of 41% in mixed disulphide at the end of HD, i.e. similar to the decline no effect on plasma homocysteine level in uraemic patients [24] . Therefore, depressed plasma serine levels in fHcy observed in our study.
Our results, showing reduced plasma taurine levels in such patients appear to be a consequence rather than a cause of increase in Hcy concentrations. On the in the dialysis patients are in agreement with earlier results from our group and from other groups other hand, the depressed plasma serine levels observed in CRF may reflect a decline in renal serine production, [1,7,9-11,42]. Muscle taurine (the largest body-pool of taurine) was reported to be low in the presence of because significant net serine synthesis normally occurs in the human kidney [36 ] .
low plasma taurine [1,2,8], and there was a correlation between extra-and intracellular levels [2 ], suggesting After dialysis we observed a 26% reduction in tHcy and a 22 % reduction in pbHcy, whereas serum creatin-that reduced plasma taurine levels may reflect taurine depletion. Previous studies report normal or increased ine was reduced by about 61% and urea by about 72% ( Table 3 ). The post-dialysis reduction of tHcy in this plasma taurine levels in patients with renal failure [3, 4, 6, 43] . In these studies, the analytical techniques study is in agreement with results of earlier studies [20, 37] . However, there are also conflicting results. differed from those used in the present study. It is also
